𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholangiocarcinoma complicating recurrent primary sclerosing cholangitis after liver transplantation

✍ Scribed by Shirin E. Khorsandi; Silvia Salvans; Yoh Zen; Kosh Agarwal; Wayel Jassem; Nigel Heaton

Book ID
110917652
Publisher
Springer
Year
2011
Tongue
English
Weight
330 KB
Volume
24
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recurrence of primary sclerosing cholang
Recurrence of primary sclerosing cholangitis following liver transplantation
✍ Ivo W. Graziadei; Russell H. Wiesner; Kenneth P. Batts; Paul J. Marotta; Nichola πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 311 KB πŸ‘ 2 views

Recurrence of primary sclerosing cholangitis (PSC) following liver transplantation has been suggested; however, it has not been fully defined because of numerous complicating factors and the lack of diagnostic criteria. In the present study, we investigated the recurrence of PSC by developing strict

Risk factors for recurrence of primary s
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
✍ Evangelos Cholongitas; Vibhakorn Shusang; George V. Papatheodoridis; Laura Marel πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

Liver transplantation (LT) is the only therapeutic option for end-stage primary sclerosing cholangitis (PSC), but PSC can recur (rPSC) in some patients after LT. The aim of our study was to evaluate the risk factors associated with rPSC. Between 1989 and 2004, 69 patients receiving transplantation f

Risk factors for recurrence of primary s
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation
✍ Jacob Alexander; James D. Lord; Matthew M. Yeh; Carlos Cuevas; Ramasamy Bakthava πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 2 views

Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease due to primary sclerosing cholangitis (PSC). Recurrence of PSC has recently emerged as a leading cause of allograft failure in the long term. There is limited data on risk factors for recurrence of PSC